ACS
WX

Archford Capital Strategies’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Archford Capital Strategies’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-755
Closed -$29.3K – 752
2015
Q1 		$29.3K Hold
755
– – 0.02% 249
2014
Q4 		$25K Buy
755
+118
+19% +$4.17K 0.02% 276
2014
Q3 		$22K Hold
637
– – 0.02% 291
2014
Q2 		$20.9K Hold
637
– – 0.02% 307
2014
Q1 		$23.5K Buy
+637
New +$23.4K 0.02% 302

Other funds holding WX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Archford Capital Strategies's WX Position: Q2 2015 in Review

Archford Capital Strategies sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 755 shares — an estimated $29.3K sold.

Archford Capital Strategies first reported a position in WX in Q1 2014 and held it in 5 quarters. The position peaked at $29.3K in Q1 2015. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

  • Archford Capital Strategies reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
  • Archford Capital Strategies sold 755 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $29.3K.
  • Archford Capital Strategies first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 5 quarters.
  • Archford Capital Strategies's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $29.3K in Q1 2015.
  • 154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Archford Capital Strategies's 13F filing for Q2 2015, filed 12 Aug 2015.